tiprankstipranks
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market

Invex Therapeutics Ltd. (IXC) Income Statement

Compare
2 Followers

Invex Therapeutics Ltd. Income Statement

Last quarter (Q4 2024), Invex Therapeutics Ltd.'s total revenue was AU$1.21M, an increase of 171.25% from the same quarter last year. In Q4, Invex Therapeutics Ltd.'s net income was AU$470.89K. See Invex Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00AU$ 0.00
Gross Profit
AU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00AU$ 0.00
Operating Expenses
AU$ 3.35MAU$ 8.98MAU$ 4.24MAU$ 2.44MAU$ 3.41M
Depreciation and Amortization
AU$ 2.13MAU$ 8.55MAU$ 4.03MAU$ 2.44MAU$ 3.25M
EBITDA
AU$ -720.44KAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Operating Income
AU$ -2.13MAU$ -8.55MAU$ -4.03MAU$ -2.44MAU$ -3.29M
Other Income/Expenses
AU$ -720.44KAU$ 797.08KAU$ 79.88KAU$ 158.79KAU$ -110.99K
Pretax Income
AU$ -2.85MAU$ -7.75MAU$ -3.95MAU$ -2.28MAU$ -3.36M
Net Income
AU$ -1.64MAU$ -7.75MAU$ -3.95MAU$ -2.28MAU$ -3.36M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.02AU$ -0.10AU$ -0.05AU$ -0.03AU$ -0.06
Diluted EPS
AU$ -0.02AU$ -0.10AU$ -0.05AU$ -0.03AU$ -0.06
Weighted Average Shares Outstanding
75.31M 75.15M 75.15M 75.15M 56.17M
Weighted Average Shares Outstanding (Diluted)
75.31M 75.15M 75.15M 75.15M 56.17M
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis